Two Sigma Securities »

Bioxcel Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $27k 17k 1.60

More positions owned by Two Sigma Securities

Ishares Tr Iboxx Hi Yd Etf (HYG)
Microsoft Corporation (MSFT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Core Msci Total (IXUS)
Oracle Corporation (ORCL)
Ishares Tr Core Univrsl Usd (IUSB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Broad Usd High (USHY)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)

View all positions for Two Sigma Securities

Top funds holding Bioxcel Therapeutics

Millennium Management
Vanguard Group
Oaktree Capital Management
Geode Capital Management
FMR
Jones Financial Companies, L.L
Jane Street
GSA Capital Partners
BlackRock
State Street Corporation
Man Group
Oaktree Fund Advisors
HighTower Advisors
Northern Trust
UBS Group

View all funds holding Bioxcel Therapeutics